Financials
Value Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 37.45 M33.33 M35.1 M — Research & development 10.73 M13.71 M15.19 M — Operating income 3.72 M7.53 M20.52 M — Non-Operating Income, Total -27.96 M852 K4.76 M — Interest expense, net of interest capitalized ——— — Non-Operating Income, excl. Interest Expenses 708 K1.99 M1.94 M — Unusual income/expense -28.67 M-1.14 M2.82 M — Pretax income -24.24 M8.38 M25.28 M — Equity in earnings ——— — Taxes 1.99 M1.95 M-9.2 M — Non-controlling/minority interest ——— — After tax other income/expense ——— — Net income before discontinued operations -26.23 M6.44 M34.48 M — Discontinued operations ——— — Net income -26.23 M6.44 M34.48 M — Dilution adjustment ——— — Preferred dividends ——— — Diluted net income available to common stockholders -26.23 M6.44 M34.48 M — Basic earnings per share (Basic EPS) -0.650.091.49 — Diluted earnings per share (Diluted EPS) -0.650.080.68 — Average basic shares outstanding 40.12 M73.69 M50.9 M — Diluted shares outstanding 40.12 M80.74 M50.9 M — EBITDA 4.37 M8.19 M23.15 M — EBIT 3.72 M7.53 M20.52 M — Cost of revenue 15.9 M14.79 M15.63 M — Other cost of goods sold ——— — Depreciation & amortization (cash flow) 658 K657 K2.63 M —